ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,034.91
-0.30%
US Tech 100
20,863.20
0.19%
Dow Jones
44,247.83
-0.35%
Brent Oil
72.775
1.16%
Bitcoin
98,042.27
1.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Impact Biomedical Inc (IBO) Quote

Impact Biomedical Inc

Impact Biomedical Inc (IBO)

Universal Ibogaine Inc
2.37
0.19
(8.72%)
Closed December 10 4:00PM
Delayed by 15 minutes
2.37
0.00
( 0.00% )
Pre Market: 4:00AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.37
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
1.22 52 Week Range 3.25
Previous Close
2.37
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
81,329
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

IBO Latest News

More News

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

November 19 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 12 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 04 2024
Edgar (US Regulatory)

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

October 15 2024
GlobeNewswire Inc.

Form 8-K - Current report

October 08 2024
Edgar (US Regulatory)

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

October 07 2024
GlobeNewswire Inc.

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

September 26 2024
GlobeNewswire Inc.

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

September 23 2024
GlobeNewswire Inc.

Form 8-K - Current report

September 17 2024
Edgar (US Regulatory)

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) --  Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

September 17 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.219.722222222222.162.691.58234332.2661454CS
4-0.28-10.56603773582.653.251.58450152.68247515CS
120.062.59740259742.313.251.22813292.28148698CS
26-0.63-2133.251.22832622.29810664CS
52-0.63-2133.251.22832622.29810664CS
156-0.63-2133.251.22832622.29810664CS
260-0.63-2133.251.22832622.29810664CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZONECleanCore Solutions Inc
$ 1.92
(50.00%)
669.44k
EPEmpire Petroleum Corporation
$ 7.99
(13.33%)
1
TOONKartoon Studios Inc
$ 0.644
(8.09%)
441
SENSSenseonics Holdings Inc
$ 0.3302
(7.38%)
1.53k
UAMYUnited States Antimony Corp
$ 1.49
(7.19%)
829
SGNSigning Day Sports Inc
$ 3.10
(-13.65%)
10.19k
UAVSAgEagle Aerial Systems Inc
$ 5.34
(-12.03%)
7.67k
EVBNEvans Bancorp Inc
$ 41.91
(-6.83%)
3
SOARVolato Group Inc
$ 0.2735
(-5.56%)
131.62k
CVUCPI Aerostructures Inc
$ 3.52
(-5.12%)
13
BURUNuburu Inc
$ 0.4325
(0.35%)
3.78M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
$ 1.01
(-1.46%)
1.66M
ZONECleanCore Solutions Inc
$ 1.92
(50.00%)
669.44k
GSATGlobalstar Inc
$ 2.32
(1.31%)
616.26k
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 27.57
(1.88%)
539.55k

IBO Discussion

View Posts
Disquisition Disquisition 2 months ago
INCREDIBLE DUMPING
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
IBO...BOTTOM BOUNCER
👍️0
rizah rizah 2 years ago
All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.
👍️0
harry_brat harry_brat 2 years ago
$IBO held on to its renowned capital market advisor

UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.
👍️0
Blue_Digital_Media Blue_Digital_Media 2 years ago
Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

Watch now IBO for latest stock information.
👍️0

Your Recent History

AMEX
IBO
Impact Biomedical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved